Avastin® Herceptin® Breast cancer HER 2+ About Herceptin® Herceptin® development Administration Efficacy Adjunvant efficacy Neoadjuvant efficacy Metastasic breast cancer efficacy Safety Cardiac safety Dosage Mabthera® Tarceva® Xeloda®

Home/EN/Product information/Herceptin®/Efficacy/Efficacy Efficacy  Adjuvant efficacy Neoadjunvant efficacy Metastasic breast cancer efficacy

Privacy Policy | Legal Statement The information on this Web site is intended only for visitors from Aruba, Bahamas, Barbados, Bermuda, Curacao, Jamaica, St. Maarten, St. Lucia and Trinidad & Tobago All rights reserved © 2008 F. Hoffmann-La Roche Ltd.